Exact Sciences

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Oncotype DX Breast Recurrence Score^® Test and the Cologuard^® stool DNA-based colorectal cancer screening test¹ , Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. We serve patients in more than 90 countries and our Oncotype DX^® test is the most commonly used genomic assay in the NHS for adjuvant chemotherapy treatment decision-making.

To learn more, please visit our website or you can reach our Customer Support Team at europeansupport@exactsciences.com or on 020 3031 8087

^{This product is only available in the US}